glp-1 and gout Targeting GLP-1, GIP & GCG in Obesity Type 2 Diabetes Research Current Insights, Advantages and Challenges

When people stop taking them, they are essentially taking their foot off the brake, and this can lead to rapid weight regain. The researchers say there are several reasons why people may not return to their original weight even a year after stopping the medications

The battle of the prescription weight loss drugs continues

Artificial intelligence can support target identification, clinical trial design, biomarker discovery, patient stratification, real-world evidence generation, and safety monitoring

Wu, H., Yang, W., Guo, T

doi: 10.1016/j.atherosclerosis.2017.04.001 131 PoulterNRPrabhakaranDCaulfieldM

2024 May 17 [cited 2025 Oct 21];27(5)